Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Myc and YAP roles in the control of the cell cycle [MEF RNA-seq pharmacological treatment]

ABSTRACT: Expression profiling by RNA-seq

ORGANISM(S): Mus musculus

PROVIDER: GSE107583 | GEO | 2017/12/01

SECONDARY ACCESSION(S): PRJNA420726

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Myc and YAP roles in the control of the cell cycle [3T9 RNA-seq pharmacological treatment]

Project description:RNAseq analysis of YAP and Myc induced in quiescent and confluent 3T9 fibroblasts treated with Y27632 and Verteporfin

2017-11-22 | GSE83868 | GEO

Myc and YAP roles in the control of the cell cycle [MEF RNA-seq pharmacological treatment]

Project description:Myc and YAP roles in the control of the cell cycle [MEF RNA-seq pharmacological treatment]

| PRJNA420726 | ENA

Myc and YAP roles in the control of the cell cycle

Project description:This SuperSeries is composed of the SubSeries listed below.

2017-11-22 | GSE83869 | GEO

Myc and YAP roles in the control of the cell cycle [3T9 RNA-seq]

Project description:RNAseq analysis of YAP and Myc induced in quiescent and confluent 3T9 fibroblasts

2017-11-22 | GSE83867 | GEO

Myc and YAP roles in the control of the cell cycle [Liver RNA-seq]

Project description:RNAseq analysis was performed on liver of tet-YAP and tet-Myc transgenic mice induced for 2 days (R26-mice) or 4 weeks (laptTA-mice) or in liver tumor noduli.

2017-11-22 | GSE83865 | GEO

Myc and YAP roles in the control of the cell cycle [3T9 ChIP-seq]

Project description:ChIPseq analysis of YAP and Myc induced in quiescent and confluent 3T9 fibroblasts

2017-11-22 | GSE83866 | GEO

Myc and YAP roles in the control of the cell cycle [Liver ChIP-seq]

Project description:ChIPseq analysis was performed on liver of tet-YAP and tet-Myc transgenic mice induced for 2 days (R26-mice)

2017-11-22 | GSE83863 | GEO

Myc and YAP roles in the control of the cell cycle

Project description:Myc and YAP roles in the control of the cell cycle

| PRJNA327238 | ENA

Long noncoding RNA EMS connects c-Myc to cell cycle control and tumorigenesis.

Project description:Deregulated expression of c-Myc is an important molecular hallmark of cancer. The oncogenic function of c-Myc has been largely attributed to its intrinsic nature as a master transcription factor. Here, we report the long noncoding RNA (lncRNA) E2F1 messenger RNA (mRNA) stabilizing factor (EMS) as a direct c-Myc transcriptional target. EMS functions as an oncogenic molecule by promoting G1/S cell cycle progression. Mechanistically, EMS cooperates with the RNA binding protein RALY to stabilize E2F1 mRNA, and thereby increases E2F1 expression. Furthermore, EMS is able to connect c-Myc to cell cycle control and tumorigenesis via modulating E2F1 mRNA stability. Together, these findings reveal a previously unappreciated mechanism through which c-Myc induces E2F1 expression and also implicate EMS as an important player in the regulation of c-Myc function.

| S-EPMC6642410 | biostudies-literature

MEF-2 isoforms' (A-D) roles in development and tumorigenesis.

Project description:Myocyte enhancer factor (MEF)-2 plays a critical role in proliferation, differentiation, and development of various cell types in a tissue specific manner. Four isoforms of MEF-2 (A-D) differentially participate in controlling the cell fate during the developmental phases of cardiac, muscle, vascular, immune and skeletal systems. Through their associations with various cellular factors MEF-2 isoforms can trigger alterations in complex protein networks and modulate various stages of cellular differentiation, proliferation, survival and apoptosis. The role of the MEF-2 family of transcription factors in the development has been investigated in various cell types, and the evolving alterations in this family of transcription factors have resulted in a diverse and wide spectrum of disease phenotypes, ranging from cancer to infection. This review provides a comprehensive account on MEF-2 isoforms (A-D) from their respective localization, signaling, role in development and tumorigenesis as well as their association with histone deacetylases (HDACs), which can be exploited for therapeutic intervention.

| S-EPMC6505634 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data